EMD-14784
AMC009 SOSIPv5.2 + ACS110 Fab
EMD-14784
Single-particle25.0 Å
Deposition: 15/04/2022Map released: 02/11/2022
Last modified: 30/11/2022
Sample Organism:
Homo sapiens
Sample: AMC009 SOSIPv5.2 in complex with ACS110 Fab
Deposition Authors: van Schooten J
,
Ward A
Sample: AMC009 SOSIPv5.2 in complex with ACS110 Fab
Deposition Authors: van Schooten J
,
Ward A
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer.
van Schooten J ,
Schorcht A ,
Farokhi E,
Umotoy JC,
Gao H,
van den Kerkhof TLGM,
Dorning J,
Rijkhold Meesters TG,
van der Woude P,
Burger JA,
Bijl T,
Ghalaiyini R,
Torrents de la Pena A,
Turner HL,
Labranche CC,
Stanfield RL ,
Sok D,
Schuitemaker H,
Montefiori DC,
Burton DR,
Ozorowski G,
Seaman MS,
Wilson IA,
Sanders RW,
Ward AB,
van Gils MJ
(2022) PLoS Pathog , 18 , e1010945 - e1010945
,
Schorcht A ,
Farokhi E,
Umotoy JC,
Gao H,
van den Kerkhof TLGM,
Dorning J,
Rijkhold Meesters TG,
van der Woude P,
Burger JA,
Bijl T,
Ghalaiyini R,
Torrents de la Pena A,
Turner HL,
Labranche CC,
Stanfield RL ,
Sok D,
Schuitemaker H,
Montefiori DC,
Burton DR,
Ozorowski G,
Seaman MS,
Wilson IA,
Sanders RW,
Ward AB,
van Gils MJ
(2022) PLoS Pathog , 18 , e1010945 - e1010945
Grant Support:
- Bill & Melinda Gates Foundation: OPP1115782 (United States)
- Bill & Melinda Gates Foundation: INV-002916 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): AI110657 (United States)